Five preventable causes of kidney graft loss in the 1990s: a single-center analysis.

BACKGROUND Despite improvements in immunosuppressive protocols and patient care, kidney allografts continue to fail. We studied causes of graft loss for primary kidney transplants in the 1990s to determine major causes and potential interventions. METHODS Causes of graft loss were reviewed for 1467 primary kidney transplants done at our institution between January 1, 1990, and December 31, 1999. Graft loss for that entire population was studied and then the causes of loss selectively examined at <1 year, 1 to 5 years, and>5 years post-transplant. Finally, causes of loss in the 1990s versus the 1980s were compared. RESULTS Five major causes of graft loss were noted in the 1990s: thrombosis, acute rejection (either alone or combined with delayed graft function or infection), chronic rejection, death with function, and noncompliance. In the first year post-transplant, thrombosis (25%) and death with function (41%) were the major causes of graft loss. After the first year, chronic rejection and death with function predominated. For recipients dying with graft function, cardiovascular disease was the major cause of death. CONCLUSIONS This study identified the five major causes of kidney graft loss in the 1990s. Different interventions are required to decrease loss from each of these causes. Future research needs to be directed at such interventions.

[1]  K. Rootwelt,et al.  Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril. , 2001, Transplantation.

[2]  F. Delmonico,et al.  Transplant Kidneys Sooner: Discard Fewer Kidneys , 2001, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[3]  M. Skeans,et al.  The natural history of azathioprine compliance after renal transplantation. , 2001, Kidney international.

[4]  H. Parving,et al.  The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. , 2001, The New England journal of medicine.

[5]  B. Brenner,et al.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. , 2001, The New England journal of medicine.

[6]  Michael Green.  Management of Epstein–Barr Virus‐induced Post‐transplant Lymphoproliferative Disease in Recipients of Solid Organ Transplantation , 2001, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[7]  A. Åsberg,et al.  Better microvascular function on long-term treatment with lisinopril than with nifedipine in renal transplant recipients. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  A. Matas,et al.  Peri‐operative cardiac morbidity in kidney transplant recipients: incidence and risk factors , 2001, Clinical transplantation.

[9]  M. Mitsnefes,et al.  Short‐term pediatric renal transplant survival: Blood pressure and allograft function , 2001, Pediatric transplantation.

[10]  D. Gjertson,et al.  Clinical impact of delayed graft function for kidney transplantation , 2001 .

[11]  M. Joffe,et al.  Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. , 2001, The New England journal of medicine.

[12]  G. Appel,et al.  Antiphospholipid antibody syndrome and renal disease , 2001, Current opinion in nephrology and hypertension.

[13]  R. Wolfe,et al.  Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. , 2001, Journal of the American Society of Nephrology : JASN.

[14]  A. Sánchez-Fructuoso,et al.  DOES RENAL MASS EXERT AN INDEPENDENT EFFECT ON THE DETERMINANTS OF ANTIGEN-DEPENDENT INJURY? , 2001, Transplantation.

[15]  F. Port,et al.  Effect of waiting time on renal transplant outcome. , 2000, Kidney international.

[16]  A. Matas,et al.  PRE-EMPTIVE TRANSPLANTS FOR PATIENTS WITH RENAL FAILURE: An Argument Against Waiting Until Dialysis , 2000, Transplantation.

[17]  R. Elashoff,et al.  Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. , 2000, The New England journal of medicine.

[18]  D. Churchill,et al.  Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada. , 2000, Journal of the American Society of Nephrology : JASN.

[19]  B. Dahlbäck,et al.  Factor V R506Q mutation (activated protein C resistance) is an additional risk factor for early renal graft loss associated with acute vascular rejection. , 2000, Transplantation.

[20]  P. Kimball,et al.  Frequency, potential risk and therapeutic intervention in end-stage renal disease patients with antiphospholipid antibody syndrome: a multicenter study. , 2000, Transplantation.

[21]  S. Hariharan,et al.  Improved graft survival after renal transplantation in the United States, 1988 to 1996. , 2000, The New England journal of medicine.

[22]  A. Matas,et al.  Immunologic factors: the major risk for decreased long-term renal allograft survival. , 1999, Transplantation.

[23]  R. Wolfe,et al.  Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. , 1999, The New England journal of medicine.

[24]  J. Stone,et al.  Antiphospholipid antibody syndrome in renal transplantation: occurrence of clinical events in 96 consecutive patients with systemic lupus erythematosus. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  A. Irish,et al.  Renal allograft thrombosis: can thrombophilia explain the inexplicable? , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[26]  D. Dunn,et al.  Decreased acute rejection in kidney transplant recipients is associated with decreased chronic rejection. , 1999, Annals of surgery.

[27]  B. Tönshoff,et al.  Heterozygous prothrombin gene mutation: a new risk factor for early renal allograft thrombosis. , 1999, Transplantation.

[28]  F. Cosio,et al.  Patient survival after renal transplantation: II. The impact of smoking , 1999, Clinical transplantation.

[29]  J. Mcintyre,et al.  Antiphospholipid antibodies are a risk factor for early renal allograft failure. , 1999, Transplantation.

[30]  R. Gaston,et al.  Late renal allograft loss: noncompliance masquerading as chronic rejection. , 1999, Transplantation proceedings.

[31]  H. Geiger,et al.  Hypertension is associated with hyperlipidemia, coronary heart disease and chronic graft failure in kidney transplant recipients. , 1999, Clinical nephrology.

[32]  R. Wolfe,et al.  Dialysis modality and the risk of allograft thrombosis in adult renal transplant recipients. , 1999, Kidney international.

[33]  A. Tosetto,et al.  Activated Protein C Resistance and Factor V Leiden Mutation Are Independent Risk Factors for Venous Thromboembolism , 1999, Annals of Internal Medicine.

[34]  A. Matas.  Noncompliance and late graft loss: Implications for long-term clinical studies , 1999 .

[35]  P. Nickerson,et al.  Beneficial effects of treatment of early subclinical rejection: a randomized study. , 1998, Journal of the American Society of Nephrology : JASN.

[36]  M. Pfeffer,et al.  Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[37]  G. Remuzzi,et al.  Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial , 1998, The Lancet.

[38]  A. Matas.  Risk factors for chronic rejection--a clinical perspective. , 1998, Transplant immunology.

[39]  F. Cosio,et al.  Patient survival after renal transplantation: I. The impact of dialysis pre-transplant , 1998 .

[40]  B. Brenner,et al.  Antigen-independent determinants of graft survival in living-related kidney transplantation. , 1997, Kidney international. Supplement.

[41]  A. Matas,et al.  Effect of initial slow graft function on renal allograft rejection and survival. , 1997, Clinical transplantation.

[42]  A. Matas,et al.  Effect of early cyclosporine levels on kidney allograft rejection. , 1997, Clinical transplantation.

[43]  P. Morris,et al.  The factor V Leiden (R506Q) mutation and risk of thrombosis in renal transplant recipients. , 1997, Transplantation.

[44]  E. Racadot,et al.  Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients. , 1997, Transplantation.

[45]  R. Wolfe,et al.  Delayed graft function: risk factors and implications for renal allograft survival. , 1997, Transplantation.

[46]  B. Brenner,et al.  Antigen-independent determinants of cadaveric kidney transplant failure. , 1996, JAMA.

[47]  B. Chavers,et al.  The importance of early cyclosporine levels in pediatric kidney transplantation. , 1996, Clinical transplantation.

[48]  F. Locatelli,et al.  Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency , 1996 .

[49]  D. Rush,et al.  Effect of subclinical rejection on renal allograft histology and function at 6 months. , 1996, Transplantation proceedings.

[50]  H. Hricak.  Imaging of the genitourinary system. , 1995, Academic radiology.

[51]  A. Matas,et al.  Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. , 1995, Transplantation.

[52]  K. Byth,et al.  Renal graft thrombosis. A survey of 134 consecutive cases. , 1994, Transplantation.

[53]  D. Gjertson,et al.  The hyperfiltration hypothesis in human renal transplantation. , 1994, Transplantation.

[54]  G. Appel,et al.  Renal transplantation in anticardiolipin antibody-positive lupus erythematosus patients. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[55]  R. Bain,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. , 1993, The New England journal of medicine.

[56]  R. Bain,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1993 .

[57]  G. Mayer,et al.  THE EFFECTS OF LISINOPRIL ON RENAL FUNCTION IN PROTEINURIC RENAL TRANSPLANT RECIPIENTS , 1993, Transplantation.

[58]  D. Dunn,et al.  Early versus late acute renal allograft rejection: impact on chronic rejection. , 1993 .

[59]  D. Dunn,et al.  Risk factors for chronic rejection in renal allograft recipients. , 1993, Transplantation.

[60]  R. Wilson,et al.  Prevalence of, and risk factors for, angiographically determined coronary artery disease in type I-diabetic patients with nephropathy. , 1992, Archives of internal medicine.

[61]  R. Wilson,et al.  Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure , 1992, The Lancet.

[62]  B. Brenner,et al.  In renal transplantation, one size may not fit all. , 1992, Journal of the American Society of Nephrology : JASN.

[63]  D. Dunn,et al.  Causes of Renal Allograft Loss: Progress in the 1980s, Challenges for the 1990s , 1991, Annals of surgery.

[64]  R. Wolfe,et al.  Long-term survival in renal transplant recipients with graft function. , 2000, Kidney international.

[65]  X. Lens,et al.  Long-term anti-proteinuric effect of Losartan in renal transplant recipients treated for hypertension. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[66]  D. Dunn,et al.  5,000 kidney transplants--a single-center experience. , 2000, Clinical transplants.

[67]  Cecka Jm.  The UNOS Scientific Renal Transplant Registry. , 1999 .

[68]  G. Opelz,et al.  Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. , 1998, Kidney international.

[69]  D. Gjertson.  The role of death in kidney graft failure. , 1998, Clinical transplants.

[70]  R. Ploeg,et al.  Primary renal graft thrombosis. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.